000 01334 a2200373 4500
005 20250512071300.0
264 0 _c19861107
008 198611s 0 0 ger d
022 _a0012-0472
024 7 _a10.1055/s-2008-1068658
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStimpel, M
245 0 0 _a[Therapy of primary aldosteronism].
_h[electronic resource]
260 _bDeutsche medizinische Wochenschrift (1946)
_cSep 1986
300 _a1487-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenoma
_xcomplications
650 0 4 _aAdrenal Cortex Diseases
_xcomplications
650 0 4 _aAdrenal Cortex Neoplasms
_xcomplications
650 0 4 _aAdrenalectomy
650 0 4 _aCarcinoma
_xcomplications
650 0 4 _aDiagnosis, Differential
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aHydrochlorothiazide
_xtherapeutic use
650 0 4 _aHyperaldosteronism
_xetiology
650 0 4 _aHyperplasia
650 0 4 _aMineralocorticoid Receptor Antagonists
_xtherapeutic use
650 0 4 _aSpironolactone
_xtherapeutic use
700 1 _aDralle, H
700 1 _avon zur Mühlen, A
773 0 _tDeutsche medizinische Wochenschrift (1946)
_gvol. 111
_gno. 39
_gp. 1487-8
856 4 0 _uhttps://doi.org/10.1055/s-2008-1068658
_zAvailable from publisher's website
999 _c3763512
_d3763512